Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption - Full Text View - ClinicalTrials.gov

Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption - Full Text View - ClinicalTrials.gov

Help NIAID Researchers Find New Ways to Treat HIV

NIAID researchers in Bethesda, Maryland, seek volunteers to see if an experimental treatment is safe and can control HIV infection without the need for HIV medications.

Read more about the clinical trial of Vedolizumab in Subjects With HIV Infection Undergoing Analytical Treatment Interruption (study ID NCT02788175) http://www.clinicaltrials.gov/ct2/show/NCT02788175.